IL88323A0 - Esterified azacyclic hydroxy compounds,their preparation and pharmaceutical composition containing them - Google Patents
Esterified azacyclic hydroxy compounds,their preparation and pharmaceutical composition containing themInfo
- Publication number
- IL88323A0 IL88323A0 IL88323A IL8832388A IL88323A0 IL 88323 A0 IL88323 A0 IL 88323A0 IL 88323 A IL88323 A IL 88323A IL 8832388 A IL8832388 A IL 8832388A IL 88323 A0 IL88323 A0 IL 88323A0
- Authority
- IL
- Israel
- Prior art keywords
- azacyclic
- esterified
- preparation
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH437687 | 1987-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL88323A0 true IL88323A0 (en) | 1989-06-30 |
Family
ID=4274958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL88323A IL88323A0 (en) | 1987-11-10 | 1988-11-08 | Esterified azacyclic hydroxy compounds,their preparation and pharmaceutical composition containing them |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4908371A (xx) |
| EP (1) | EP0316279A3 (xx) |
| JP (1) | JPH01157962A (xx) |
| AU (1) | AU623098B2 (xx) |
| DK (1) | DK624788A (xx) |
| IL (1) | IL88323A0 (xx) |
| PT (1) | PT88959B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9100465D0 (en) * | 1991-01-09 | 1991-02-20 | Hider Robert C | Pharmaceutical compositions |
| GB9209078D0 (en) * | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
| GB9217099D0 (en) * | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| US5789426A (en) * | 1995-01-20 | 1998-08-04 | Cornell Research Foundation, Inc. | Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
| US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| JPH0925234A (ja) * | 1995-07-12 | 1997-01-28 | Wakunaga Pharmaceut Co Ltd | 脳疾患改善剤 |
| ATE299135T1 (de) * | 1995-09-29 | 2005-07-15 | Novartis Pharma Gmbh | Hydroxypyridinone |
| US5882799A (en) * | 1996-12-16 | 1999-03-16 | Vernay Laboratories, Inc. | Polymeric coupling agents for the adhesion of macromolecular materials and metal substrates |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| JP2005516987A (ja) * | 2002-02-05 | 2005-06-09 | ブリストル−マイヤーズ スクイブ カンパニー | Ｎ−置換された３−ヒドロキシ−４−ピリジノン化合物およびそれを含む医薬 |
| WO2013097052A1 (en) | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
| US9458142B2 (en) * | 2012-12-13 | 2016-10-04 | Merck Patent Gmbh | Substituted quinones or analogues as colouring agents |
| BR112018071216A2 (pt) | 2016-04-15 | 2019-02-05 | Abbvie Inc | inibidores de bromodomínios |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0094149B1 (en) * | 1982-03-24 | 1986-09-10 | National Research Development Corporation | Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8325494D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
| GB8410289D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
-
1988
- 1988-11-01 US US07/265,646 patent/US4908371A/en not_active Expired - Fee Related
- 1988-11-04 EP EP88810756A patent/EP0316279A3/de not_active Withdrawn
- 1988-11-08 IL IL88323A patent/IL88323A0/xx unknown
- 1988-11-08 PT PT88959A patent/PT88959B/pt not_active IP Right Cessation
- 1988-11-09 DK DK624788A patent/DK624788A/da not_active Application Discontinuation
- 1988-11-09 AU AU24936/88A patent/AU623098B2/en not_active Ceased
- 1988-11-09 JP JP63281495A patent/JPH01157962A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK624788D0 (da) | 1988-11-09 |
| AU2493688A (en) | 1989-05-11 |
| EP0316279A3 (de) | 1990-01-03 |
| DK624788A (da) | 1989-05-11 |
| US4908371A (en) | 1990-03-13 |
| EP0316279A2 (de) | 1989-05-17 |
| AU623098B2 (en) | 1992-05-07 |
| PT88959B (pt) | 1993-02-26 |
| PT88959A (pt) | 1988-12-01 |
| JPH01157962A (ja) | 1989-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL88156A0 (en) | Azacyclic compounds,their preparation and pharmaceutical compositions containing them | |
| GB2204792B (en) | Pharmaceutical composition | |
| ZA883167B (en) | Pharmaceutical composition | |
| GB8810765D0 (en) | Pharmaceutical composition | |
| IL87644A0 (en) | Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them | |
| IL88323A0 (en) | Esterified azacyclic hydroxy compounds,their preparation and pharmaceutical composition containing them | |
| IL90753A0 (en) | Azacyclic compounds,their preparation and pharmaceutical compositions containing them | |
| EG18652A (en) | Pharmaceutical compositions | |
| AU2345988A (en) | Pharmaceutical composition for piperidinoalkanol-decongestant combination | |
| IL86478A (en) | Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them | |
| IL86926A0 (en) | 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them | |
| IL85612A0 (en) | 4-phenylpiperidine compounds,their preparation and pharmaceutical compositions containing them | |
| IL85824A0 (en) | Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them | |
| IL89049A0 (en) | Pharmaceutical composition containing 4-aroylimidazol-2-ones | |
| GB2209938B (en) | Neomycin-containing pharmaceutical compositions | |
| GB8711432D0 (en) | Pharmaceutical composition | |
| GB8705900D0 (en) | Pharmaceutical composition | |
| ZA881474B (en) | Pharmaceutical composition | |
| GB8720401D0 (en) | Pharmaceutical composition | |
| GB8708041D0 (en) | Pharmaceutical composition | |
| GB8725055D0 (en) | Pharmaceutical composition | |
| GB8718907D0 (en) | Pharmaceutical composition | |
| GB8716574D0 (en) | Pharmaceutical composition | |
| GB8707739D0 (en) | Pharmaceutical composition | |
| IE872168L (en) | Pharmaceutical composition |